Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis

Liver International

Volumn 33, Issue 7, 2013, Pages 975-981

  Alexopoulou, Alexandra ^a   Papadopoulos, Nikolaos ^a   Eliopoulos, Dimitrios G ^a   Alexaki, Apostolia ^b   Tsiriga, Athanasia ^b   Toutouza, Marina ^b   Pectasides, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Carbapamenase producing K. pneumonia; ESBL producing E. coli; Multidrug resistant bacteria; Quinolone resistance; Spontaneous bacterial peritonitis; Third generation cephalosporin resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; COLISTIN; METICILLIN; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEALTHCARE ASSOCIATED INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STREPTOCOCCUS;

CARBAPAMENASE-PRODUCING K. PNEUMONIA; ESBL-PRODUCING E. COLI; MULTIDRUG-RESISTANT BACTERIA; QUINOLONE RESISTANCE; SPONTANEOUS BACTERIAL PERITONITIS; THIRD-GENERATION CEPHALOSPORIN RESISTANCE;

AGED; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; GREECE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PREVALENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84880173649     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12152     Document Type: Article

References (30)

1. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
2. Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372-8.
3. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21: 792-6.
4. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
5. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
6. Piroth L, Pechinot A, Minello A, et al. Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective study. Scand J Infect Dis 2009; 41: 847-51.
7. Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int 2005; 25: 57-61.
8. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
9. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-36.
10. Song KH, Jeon JH, Park WB, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 2009; 9: 41-6.
11. Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-61.
12. Cereto F, Molina I, González A, et al. Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2003; 17: 695-701.
13. Shaw E, Castellote J, Santín M, et al. Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study. Eur J Clin Microbiol Infect Dis 2006; 25: 291-8.
14. Cleophas V, George V, Mathew M, et al. Spontaneous fungal peritonitis in patients with hepatitis B virus-related liver disease. J Clin Gastroenterol 2000; 31: 77-9.
15. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
16. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012; 61: 297-310.
17. Reuken PA, Pletz MW, Baier M, et al. Emergence of spontaneous bacterial peritonitis due to Enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther 2012; 35: 1199-208.
18. Campillo B, Dupeyron C, Richardet JP, et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998; 26: 1066-70.
19. O'Hara A, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-93.
20. Rice LB. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 2012; 87: 198-208.
21. Umgelter A, Reindl W, Miedaner M, et al. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection 2009; 37: 2-8.
22. Lee JH, Yoon JH, Kim BH, et al. Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis. Eur J Clin Microbiol Infect Dis 2009; 28: 21-6.
23. Ben-Ami R, Rodríguez-Baño J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682.
24. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136: 834-44.
25. Heo J, Seo YS, Yim HJ, et al. Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver 2009; 3: 197-204.
26. Ariza X, Castellote J, Lora-Tamayo J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol 2012; 56: 825-32.
27. Angeloni S, Leboffe C, Parente A, et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol 2008; 14: 2757-62.
28. Psichogiou M, Tassios PT, Avlamis A, et al. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumonia in Athens, Greece: a prospective survey. J Antimicrob Chemother 2008; 61: 59-63.
29. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumonia bloodstream infections. Antimicrob Agents Chemother 2009; 53: 1868-73.
30. Piano S, Romano A, Rosi S, et al. Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumonia: the last therapeutic challenge. Eur J Gastroenterol Hepatol 2012; 24: 1234-7.